This past June, Reed Tech Life Sciences team members attended the 60th Anniversary of the DIA Global Annual Meeting in San Diego, California.
According to the Drug Information Association’s website: “The Global Annual Meeting by DIA 2024 invites industry professionals, regulators, government officials, academics, innovators, and patients to connect, collaborate, and address global and local challenges in the life sciences community. The event showcased diverse perspectives and expertise worldwide to improve current processes and promote health and well-being.”
Reed Tech was represented by Gary Saner, Caitlin Lynes, Gwen Bland, and Julia Frasch.
Highlights of the conference included CISCRP’s Medical Heroes Appreciation 5k Walk & Run Event, Innovation Theater Presentations, Content Hubs and Community Rounds, a community networking lunch, and numerous Educational Tracks.
It was an excellent opportunity for the team to connect with current and former customers and our colleagues at Greenlight Guru and Cisema. The in-person meetings provided a perfect platform for expert consultations at our exhibit booth.
We asked Caitlin Lynes, Strategic Account Manager, Life Sciences, and Julia Frasch, Account Manager, to tell us about their experiences at the conference:
“The highlight of my DIA experience was having the opportunity to meet several former and existing clients in person. A former client visited the booth and was very excited to see us. He has been a long-time client and has brought our services to each organization he has joined. He is especially an advocate for Reed Tech Navigator™ for Drug Labels and expressed interest in implementing the service at his current organization.”
It was clear that eCTD was at the top of my mind, as conversations consistently steered toward the FDA’s rapid changes and improvements to existing eCTD formats, requirements, and suggested uses, among other changes affecting regulatory operations.
Other popular subjects discussed included Considerations to Support Global Regulatory Harmonization and Access of Cell and Gene Therapy Products to Patients, and Digital Health Technology and Meaningful Change.
Caitlyn and Julia at the Reed Tech Booth
“The session on De-Mystifying AI in Healthcare was especially popular. There were many types of companies showing how they are using AI in their software and services. Several sessions were about AI in the drug/clinical/regulatory world and the potential challenges that may arise.”
Reed Tech has expanded regulatory advisory offerings to a full suite of Pharma services. Engaging with regulatory advisory services from Reed Tech can free up your team to prioritize other priorities. Let our experts help with drug labeling and listing, eDRL Coordinator Services, eCTD (Electronic Common Technical Documents), US Agent Services and other complex regulatory tasks. We’d love to help with your compliance strategy or data submission project. Contact us!